{
    "clinical_study": {
        "@rank": "4794", 
        "arm_group": [
            {
                "arm_group_label": "PTM202", 
                "arm_group_type": "Experimental", 
                "description": "PTM202 is a medical nutrition product"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The placebo is a placebo for PTM202, a food product that can not be distinguished from PTM202 by appearance, taste or odor"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether a medical nutrition product, PTM202, along\n      with standard of care, enhances recovery and reduces diarrhea morbidity in young children"
        }, 
        "brief_title": "Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Diarrhea", 
        "condition_browse": {
            "mesh_term": "Diarrhea"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  males or females between 6 months and 5 years of age\n\n          -  acute diarrhea (<48 hours) without interfering co-morbidities\n\n          -  guardian willing to have child admitted to hospital as an inpatient for 96 hours and\n             to return to the clinic with the child on Day 7 for a final evaluation\n\n          -  Guardian is willing and able to report to the Investigator information on stool\n             frequency, stool consistency and food and water intakes during the follow up phase.\n\n          -  Written informed consent must be obtained prior to admission to this study.\n\n          -  The subject has a physical examination that reveals no clinically significant\n             abnormalities other than those expected for subjects with acute infectious diarrhea.\n\n        Exclusion Criteria:\n\n          -  Suspected or confirmed cholera\n\n          -  Suspected dysentery\n\n          -  Symptom duration >48 hours at screening\n\n          -  Vomiting severity that is like to make administration and retention of test article\n             impossible\n\n          -  Severe malnutrition (defined as weight for height of less than -3 SD below median,\n             per WHO Standards (6).\n\n          -  Child already receiving antibiotics or anti-motility drugs for this diarrhea episode\n             prior to screening.\n\n          -  History of hypersensitivity or allergy to milk or egg"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01814202", 
            "org_study_id": "PTM.2012.002", 
            "secondary_id": "PR-13002"
        }, 
        "intervention": [
            {
                "arm_group_label": "PTM202", 
                "intervention_name": "PTM202", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dhaka", 
                    "country": "Bangladesh", 
                    "zip": "1212"
                }, 
                "name": "International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)"
            }
        }, 
        "location_countries": {
            "country": "Bangladesh"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind, Randomized, Placebo-controlled Clinical Trial (Pilot Phase) to Evaluate the Efficacy of a Medical Nutrition Product, PTM202, in Children With Acute Diarrhea", 
        "overall_official": {
            "affiliation": "International Centre for Diarrhoeal Disease Research, Bangladesh", 
            "last_name": "Shafiqul A Sarker, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bangladesh: Ethical Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "diarrhea duration", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01814202"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "food intake", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "stool frequency", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }, 
            {
                "measure": "stool consistency", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "PanTheryx, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PanTheryx, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}